For people with vitiligo and their caregivers
What this page helps you do
Prepare a coordinated review of every medicine, supplement, and phototherapy plan before pregnancy, during pregnancy, or while breastfeeding.
- Your task
- Understand the current definition, evidence boundary, practical burden, and questions that affect fit.
- The clinician boundary
- Diagnosis, assessment of activity and body sites, prescribing, monitoring, and personalized treatment decisions belong to a qualified clinician.
Did I cause this, or pass vitiligo to my baby during pregnancy?
Self-blame can arrive fast. No single personal mistake explains every case of vitiligo. You deserve a family-planning conversation without blame. Evidence Evidence
Why this matters
Current sources describe vitiligo as a condition shaped by immune, genetic, and other factors. They do not support turning one remembered food, stressful event, pregnancy choice, or parenting decision into the cause.
Why does pregnancy or breastfeeding change the conversation?
Because safety information is specific to the exact medicine, formulation, health context, and stage of pregnancy or breastfeeding. Review prescription topicals, oral or injected medicines, phototherapy, over-the-counter products, supplements, and traditional preparations together. Evidence Evidence
Why this matters
Treatment labels and guidelines contain different pregnancy, breastfeeding, interaction, and precaution information. A topical product and an oral medicine with a similar-sounding target are not interchangeable.
Should I stop treatment as soon as I think I may be pregnant?
Do not stop, continue, or restart a prescription from a generic list. Contact the prescriber and pregnancy-care team promptly, and use urgent local care for urgent symptoms. Evidence Evidence
Why this matters
Abruptly changing a medicine without understanding the exact product and health context can create its own uncertainty. Coordinated care is especially important when more than one clinician prescribes treatment.
Do “natural,” Ayurvedic, or homeopathic products need review too?
Yes. Natural, traditional, or homeopathic labels do not guarantee pregnancy safety, purity, or lack of interaction. Some Ayurvedic preparations may contain toxic metals, and some products labeled homeopathic contain measurable active ingredients. Evidence Evidence
Why this matters
NCCIH advises discussing Ayurvedic, herbal, and homeopathic products with health professionals, particularly during pregnancy or nursing. Product quality and content can vary.
How can I make the conversation easier across clinicians?
Keep one current list of prescriptions, nonprescription products, supplements, devices, allergies, pregnancy or breastfeeding status, and the clinician responsible for each plan. Record changes and questions rather than relying on each team to have the same chart. Evidence Evidence
Why this matters
A current treatment history supports medication reconciliation and shared decisions. It is useful whether the eventual decision is to continue, change, pause, or use supportive care only.
Questions that can change the next decision
- For your clinicianCan we review each product and why I take it?Saving keeps this on your device and needs JavaScript, which is off in this browser.
- For your clinicianWhich clinician owns and shares the final plan?Saving keeps this on your device and needs JavaScript, which is off in this browser.
Evidence and update context
This optional layer shows the evidence boundary reviewed for this page as of 2026-08-04.
- What this evidence supports
- Current sources describe vitiligo as a condition shaped by immune, genetic, and other factors. They do not support turning one remembered food, stressful event, pregnancy choice, or parenting decision into the cause.
- What it does not establish
- These sources cannot predict whether one child will develop vitiligo. We do not publish an offspring-risk number without a current, resolving primary source.
Applicability check
Who was studied?
These fields show what the cited evidence reports about the people and body sites behind outcome or safety claims. “Not reported” means the reviewed source omitted the field; “Pending exact source review” means SteadySkin has not made that determination yet.
Because safety information is specific to the exact medicine, formulation, health context, and stage of pregnancy or breastfeeding. Review prescription topicals, oral or injected medicines, phototherapy, over-the-counter products, supplements, and traditional preparations together.
- Age range
- Pending exact source review
- Condition subtype
- Pending exact source review
- Severity or extent
- Pending exact source review
- Sample size
- Pending exact source review
- Geography and care setting
- Pending exact source review
- Skin tone or phototype
- Pending exact source review
- Race
- Pending exact source review
- Ethnicity
- Pending exact source review
- Body sites
- Pending exact source review
What that means for this page: This is explicitly gated as a safety claim, but exact population extraction is still pending. It cannot publish or support an estimate of individual risk until that review is complete.
Do not stop, continue, or restart a prescription from a generic list. Contact the prescriber and pregnancy-care team promptly, and use urgent local care for urgent symptoms.
- Age range
- Pending exact source review
- Condition subtype
- Pending exact source review
- Severity or extent
- Pending exact source review
- Sample size
- Pending exact source review
- Geography and care setting
- Pending exact source review
- Skin tone or phototype
- Pending exact source review
- Race
- Pending exact source review
- Ethnicity
- Pending exact source review
- Body sites
- Pending exact source review
What that means for this page: This is explicitly gated as a safety claim, but exact population extraction is still pending. It cannot publish or support an estimate of individual risk until that review is complete.
Yes. Natural, traditional, or homeopathic labels do not guarantee pregnancy safety, purity, or lack of interaction. Some Ayurvedic preparations may contain toxic metals, and some products labeled homeopathic contain measurable active ingredients.
- Age range
- Pending exact source review
- Condition subtype
- Pending exact source review
- Severity or extent
- Pending exact source review
- Sample size
- Pending exact source review
- Geography and care setting
- Pending exact source review
- Skin tone or phototype
- Pending exact source review
- Race
- Pending exact source review
- Ethnicity
- Pending exact source review
- Body sites
- Pending exact source review
What that means for this page: This is explicitly gated as a safety claim, but exact population extraction is still pending. It cannot publish or support an estimate of individual risk until that review is complete.
Evidence behind this page
Sources
Each evidence badge opens the source and its limits. The full list stays available here.
- Journal of the European Academy of Dermatology and VenereologyRegulatory / guideline · not independentRelevant relationship disclosed
- Published
- 2023-09-15
- SteadySkin last checked
- 2026-07-31
What this source can and cannot tell you
Why the independence label says this: The journal is the publisher. This label refers to extensive author relationships disclosed for the recommendation, not to the journal itself.
What this source supports
Supports an expert-consensus map of established, off-label and developing Vitiligo treatment categories and makes clear that research is continuing.
What it does not support
It is an international consensus with extensive author relationships, not independent comparative proof, current U.S. regulatory status for every option or a personal treatment sequence.
Automated draft claim mapping withheld from reader-facing evidence details until clinical or editorial review is recorded. This page is not yet approved for indexing.
- U.S. Food and Drug AdministrationRegulatory / guideline · not independentIndependence not established
- Published
- 2025-09-18
- SteadySkin last checked
- 2026-08-06
What this source can and cannot tell you
What this source supports
Supports the defined US nonsegmental-vitiligo indication, limitations of use, boxed warnings, skin-cancer and ultraviolet precautions, and clinical-study labeling.
What it does not support
It does not guarantee benefit, establish suitability beyond the labeled population or authorize adding phototherapy.
Automated draft claim mapping withheld from reader-facing evidence details until clinical or editorial review is recorded. This page is not yet approved for indexing.
- National Center for Complementary and Integrative HealthPatient education · independentIndependent source
- Published
- 2019-01-01
- SteadySkin last checked
- 2026-07-31
What this source can and cannot tell you
What this source supports
Supports that Ayurveda includes varied products and practices, that high-quality evidence is limited for many health claims and that some preparations may contain toxic metals.
What it does not support
It does not evaluate a specific vitiligo product, establish repigmentation benefit or treat an entire tradition as one intervention.
Automated draft claim mapping withheld from reader-facing evidence details until clinical or editorial review is recorded. This page is not yet approved for indexing.
- National Center for Complementary and Integrative HealthPatient education · independentIndependent source
- Published
- 2021-04-01
- SteadySkin last checked
- 2026-07-31
What this source can and cannot tell you
What this source supports
Supports that evidence does not establish homeopathy as effective for a specific health condition and that some labeled products can contain active ingredients with side effects or interactions.
What it does not support
It is not a vitiligo trial, an assessment of every individual product or a substitute for product-specific safety review.
Automated draft claim mapping withheld from reader-facing evidence details until clinical or editorial review is recorded. This page is not yet approved for indexing.
- Journal of the European Academy of Dermatology and VenereologyRegulatory / guideline · not independentRelevant relationship disclosed
- Published
- 2023-09-25
- SteadySkin last checked
- 2026-07-31
What this source can and cannot tell you
Why the independence label says this: The journal is the publisher. This label refers to extensive author relationships disclosed for the recommendation, not to the journal itself.
What this source supports
It supports current expert-consensus terminology, clinical assessment, disease-activity evaluation, treatment-goal discussion, and shared decision-making.
What it does not support
It is not independent comparative proof. It cannot diagnose a reader from a description or photograph.
Automated draft claim mapping withheld from reader-facing evidence details until clinical or editorial review is recorded. This page is not yet approved for indexing.
- British Journal of Dermatology (Eleftheriadou V, et al.)Regulatory / guideline · independentIndependent source
- Published
- 2022-01-01
- SteadySkin last checked
- 2026-07-31
What this source can and cannot tell you
What this source supports
Supports the clinical history and assessment domains, evaluation of associated autoimmune conditions, its recommendation for thyroid function and antithyroid antibody screening, current classification context, treatment-option map, psychosocial assessment, medical photography and the limits of pediatric evidence.
What it does not support
It was designed for UK care and reviewed literature through May 2019; it does not establish a universal testing plan, prescribe an individual plan, or establish current US labeling or coverage.
Automated draft claim mapping withheld from reader-facing evidence details until clinical or editorial review is recorded. This page is not yet approved for indexing.
- National Institute of Arthritis and Musculoskeletal and Skin DiseasesPatient education · independentIndependent source
- Published
- 2022-10-01
- SteadySkin last checked
- 2026-07-31
What this source can and cannot tell you
What this source supports
Supports a patient-facing description of clinician diagnosis using history and examination, possible use of a Wood lamp and selected tests, broad treatment categories, variable response and whole-person support.
What it does not support
It is educational context, not primary efficacy evidence, an online diagnostic method or a universal testing checklist.
Automated draft claim mapping withheld from reader-facing evidence details until clinical or editorial review is recorded. This page is not yet approved for indexing.